Venn Life Sciences is an Integrated Drug Development Partner offering a
unique combination of drug development expertise and clinical trial
design and management. This enables us to create, plan and execute drug
and medical device development programs effectively and seamlessly for
our clients. We have dedicated operations in Ireland, France, Germany, the
Netherlands, the UK, the US, and European-wide representation.
- Clinical Pharmacology
- Drug Candidate Selection
- Regulatory Affairs
- Non-clinical / Pre-clinical development
- In-licensing & Technical Due Diligence
Open Orphan (LON:ORPH) was founded in 2017, with the goal of rapidly building Europe’s leading pharma services company by a management team with extensive industry and financial expertise. The company comprises of two commercial specialist CRO services businesses (Venn Life Sciences and hVIVO) and is also developing a genomics data platform business (Genomic Health Data).